You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative neoplasms

Showing 1 - 25 of 1,076
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumors Trial (INCA033989)

Not yet recruiting
  • Myeloproliferative Neoplasms
  • (no location specified)
Sep 11, 2023

Epigenetic Age on Clinic-biological Presentation and Prognosis

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Assessment of the epigenetic age
  • Bordeaux, France
    CHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

      Not yet recruiting
      • Myeloproliferative Disorders
      • +3 more
      • (no location specified)
      Nov 21, 2023

      Action of Interferon in Treatment of Myeloproliferative

      Recruiting
      • Myeloproliferative Neoplasm
        • Villejuif, Ile De France, France
          Inserm U1287
        Apr 28, 2023

        Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

        Not yet recruiting
        • Myeloproliferative Neoplasms (MPNs)
        • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
        • (no location specified)
        Mar 24, 2023

        Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

        Recruiting
        • Myeloproliferative Neoplasm
        • Fedratinib Pill
        • Tampa, Florida
          Moffitt Cancer Center
        Nov 28, 2022

        Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Jan 6, 2023

        Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

        Not yet recruiting
        • Myelofibrosis (PMF)
        • +2 more
        • New York, New York
          Ruttenberg Treatment Center
        Apr 18, 2023

        Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

        Recruiting
        • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
        • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 6, 2023

        Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

        Not yet recruiting
        • Bone Marrow Fibrosis
        • Myeloproliferative Neoplasm
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        Jan 30, 2023

        Monocytes Sub-populations in Thrombosis Associated With

        Recruiting
        • Myeloproliferative Neoplasm
        • 1 additional tube of blood
        • Bordeaux, France
        • +4 more
        Nov 30, 2022

        Philadelphia Negative Myeloproliferative Tumors Trial

        Not yet recruiting
        • Philadelphia Negative Myeloproliferative Neoplasms
          • (no location specified)
          Jun 5, 2022

          Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

          Recruiting
          • Myeloproliferative Neoplasm
          • +2 more
          • Fedratinib Pill
          • Tampa, Florida
            Moffitt Cancer Center
          Jun 15, 2022

          Thrombotic Complications (CLOJAK)

          Not yet recruiting
          • Myeloproliferative Neoplasm
          • Blood sampling
          • Angers, France
          • +10 more
          Apr 20, 2023

          Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

          Not yet recruiting
          • Clonal Cytopenia of Undetermined Significance
          • +4 more
          • Biospecimen Collection
          • +6 more
          • Los Angeles, California
          • +1 more
          Oct 4, 2023

          Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

          Enrolling by invitation
          • Myelodysplastic/Myeloproliferative Neoplasms
          • Adult
          • venetoclax combined with azacitidine
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow University, Jiangsu Ins
          Mar 7, 2022

          Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

          Recruiting
          • Myeloproliferative Neoplasms
          • Birmingham, Alabama
          • +16 more
          Jan 27, 2023

          Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

          Recruiting
          • Myeloproliferative Neoplasms
          • Herston, Queensland, Australia
          • +22 more
          Jun 30, 2023

          Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

          Recruiting
          • Acute Myeloid Leukemia
          • +8 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Aug 18, 2022

          ph Negative Myeloproliferative Neoplasms: Impact on Outcome and

          Recruiting
          • Myeloproliferative Disease
          • Inflammatory Markers
            • Bari, Italy
            • +10 more
            Oct 21, 2022

            MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

            Recruiting
            • Myelodysplastic Syndromes
            • +2 more
            • Tampa, Florida
              Moffitt Cancer Center
            Feb 16, 2023

            Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

            Recruiting
            • Primary Myelofibrosis
            • +9 more
            • Observational
            • Toronto, Ontario, Canada
              Princess Margaret Cancer Centre
            Apr 11, 2022

            Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

            Not yet recruiting
            • Myeloproliferative Neoplasm
            • Toronto, Ontario, Canada
              Princess Margaret Cancer Centre
            Apr 12, 2022